Abstract
The humoral immune response, a key arm of adaptive immunity, consists of B cells and their products. Upon infection or vaccination, B cells undergo a Darwinian evolutionary process in germinal centers (GCs), resulting in the production of antibodies and memory B cells. We developed a computational model to study how humoral memory is recalled upon reinfection or booster vaccination. We find that upon reexposure to the same antigen, affinity-dependent selective expansion of available memory B cells outside GCs (extragerminal center compartments [EGCs]) results in a rapid response made up of the best available antibodies. Memory B cells that enter secondary GCs can undergo mutation and selection to generate even more potent responses over time, enabling greater protection upon subsequent exposure to the same antigen. GCs also generate a diverse pool of B cells, some with low antigen affinity. These results are consistent with our analyses of data from humans vaccinated with two doses of a COVID-19 vaccine. Our results further show that the diversity of memory B cells generated in GCs is critically important upon exposure to a variant antigen. Clones drawn from this diverse pool that cross-react with the variant are rapidly expanded in EGCs to provide the best protection possible while new secondary GCs generate a tailored response for the new variant. Based on a simple evolutionary model, we suggest that the complementary roles of EGC and GC processes we describe may have evolved in response to complex organisms being exposed to evolving pathogen families for millennia.
Original language | English |
---|---|
Article number | e2205598119 |
Journal | Proceedings of the National Academy of Sciences of the United States of America |
Volume | 119 |
Issue number | 37 |
DOIs | |
State | Published - 13 Sep 2022 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2022 the Author(s). Published by PNAS.
Funding
ACKNOWLEDGMENTS. M.V.B. was supported by National Institutes of Health grant no. U19AI057229; M.V.B. and A.K.C. were supported by the Ragon M.V.B. was supported by National Institutes of Health grant no. U19AI057229; M.V.B. and A.K.C. were supported by the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard; and M.C.N. is an HHMI investigator.
Funders | Funder number |
---|---|
Ragon Institute of Massachusetts General Hospital | |
National Institutes of Health | |
Howard Hughes Medical Institute | |
National Institute of Allergy and Infectious Diseases | U19AI057229 |
Massachusetts Institute of Technology | |
Harvard University |
Keywords
- affinity maturation
- antibody response
- immune memory
- vaccine
- virus